110 results
8-K
EX-99.1
BCRX
Biocryst Pharmaceuticals Inc.
27 May 14
A Phase 2 Trial of BCX4161 for the Prophylactic Treatment of
12:00am
to working with clinical investigators, the HAE community and regulatory authorities in advancing BCX4161 to the next stage and starting the OPuS-2 12
8-K
EX-99.1
BCRX
Biocryst Pharmaceuticals Inc.
7 Aug 18
BioCryst Reports Second Quarter 2018 Financial Results
7:31am
shareholders and a strong conviction in the medical community that BCX7353 is a highly differentiated asset which can deliver enormous value
425
BCRX
Biocryst Pharmaceuticals Inc.
22 Jan 18
Business combination disclosure
12:00am
and immediately forms a substantial and differentiated biotech company serving patients in the rare disease community,” stated Jon P. Stonehouse, BioCryst’s
425
BCRX
Biocryst Pharmaceuticals Inc.
9 May 18
Business combination disclosure
6:35am
) , the oncology community feedback was very clear that response rate in people who have failed already a checkpoint inhibitor of about double the response rate
425
pig917u2
22 Jan 18
Business combination disclosure
12:00am
425
4wdyyca1grbjbvrjta5h
23 Jan 18
Business combination disclosure
12:00am